Capital Raising & Corporate Finance
Pfizer’s $43B Pursuit Of Seagen: Q&A With Séverine Piot-Deval
Pfizer’s $31 billion bond sale to fund its $43 billion acquisition of cancer drug maker Seagen is one of the largest in history. Healthcare expert Severine Piot-Deval discusses the deal with Global Finance.